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Tobacco exposure increases mortality and morbidity of the fetus, the child, the adolescent,
and their children in turn. Nearly half the children in the world are exposed. Smoking is
not merely personal choice or personal responsibility; those subtle phrases undermine
those who have no choice in the matter.Tobacco control must take a multi-pronged attack.
Smoking cessation by adults in childbearing years must take center stage of these efforts,
because it is the only way to ensure a smoke-free environment for children. Smoke-free
parents provide a role model for smoke-free young people, and erode the image of smok-
ing as a desirable adult behavior to emulate. Pediatricians and pediatric pulmonologists
have a key role to play here. This goal will reduce morbidity and mortality among adults
and children. Legislation regarding taxation, environments, tobacco constituents, product
placement and display, packaging, and media education are all key to this core goal. Smoke-
free policy must be protected from attack based on trade agreements. Research is needed
into more effective ways to attract and help people give up smoking, and into educating
and re-deploying tobacco industry workers in emerging and developed countries.
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“A custome lothsome to the eye, hatefull to the Nose,
harmefull to the braine, dangerous to the Lungs” [sic]
Since 1604 when James I of England wrote the above description
of tobacco smoking, people have recognized the common sense
link between smoking and disease, conclusively documented by
Doll and Bradford Hill (1) in the British doctors’ study. In 1967
the first effects of passive smoking on children were sought (2),
but it was not until 1981 that Hirayama’s study of non-smoking
women showed that passive smoking was a serious risk to health
(3). The massive extent and prevalence of disease attributable
to tobacco smoke exposure in children has slowly emerged and
continues to be documented (Table 1). Cigarette smoke con-
tains many carcinogens and cellular poisons that are especially
high in sidestream smoke (4), but nicotine itself is a neural
teratogen, a genotoxin and potentially a carcinogen in its own
right (5–8).
The tobacco industry maintained there was doubt about the
links of tobacco smoking with lung cancer and other health con-
cerns, and denied the addictiveness of cigarettes into the 1990s.
However, once the internal memos of tobacco companies were
forced into the public arena by landmark court cases, they were
compelled, on the surface at least, to admit some of the harm of
smoking (while continuing to this day to indicate there is doubt
about key findings). They framed this damage in terms of personal
choice and personal responsibility. People knew the risks and they
chose the pleasure of smoking in spite of this; the industry seems
almost to imply it has a responsibility to continue to supply this
legal consumer demand.
CHILDREN DO NOT HAVE A PERSONAL CHOICE
Addiction, passive smoking, and the risks to children totally negate
the argument of personal choice and personal responsibility. A
parent who is addicted to nicotine will find it extremely diffi-
cult not to expose their child to smoking, even if they smoke
outside the home (9, 10). And that child has no choice about
whether they are exposed. The fetus and the young child are
the most vulnerable to, and the least able to avoid, the health
consequences of exposure to smoking by their parents. Older
children and teenagers are, in addition, vulnerable to the role
modeling of smoking by their parents (11, 12), and to the
attractive portrayal of cigarettes as a badge of adulthood. Every
day nearly 100,000 young people worldwide start smoking (13).
In turn, this group becomes the next generation of smoking
parents.
Smoking exposure in the womb and in childhood increases risk
factors for adult disease, aside from the risk of the child becoming
a smoker themselves. These include (see Table 1) increased blood
pressure and serum lipids (cardiovascular disease), decreased pul-
monary function, and increased asthma severity (asthma and
COPD), and genotoxic effects which may increase the risk of adult
cancers.
So-called third-hand smoke has potential health effects on
children. Third-hand smoke is when smoke is adsorbed onto
clothing or fabric, and volatile substances then “off-gas” into the
air again. This gas contains significant amounts of carcinogens
and toxins (14). This means that smoking outside the house
does not remove the risks to children and can only be recom-
mended if it is a step toward quitting. Third-generation effects
have been documented, in which tobacco-induced DNA alter-
ations (methylation or mutations) occur in a smoker’s germ
cells, and are passed on via the germline to their children and
grandchildren (15, 16).
Pregnancy and childhood are thus periods when one person’s
smoking intensely and intimately exposes other highly vulnerable
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Table 1 | Increased fetal or child morbidity and mortality risks that have been associated with exposure to tobacco smoke (indicative, not
exhaustive).
PRE-/PERI-CONCEPTIONAL EFFECTS OF FATHER SMOKING
Anorectal malformations [pOR 1.53 (40)]
Childhood cancers [including ALL and AML (41–45)]
PRE/PERI-CONCEPTIONAL EFFECTS OF MOTHER OR BOTH PARENTS SMOKING
Hepatoblastoma [mother smoking OR=2.68, both parents OR=4.74 (46, 47)]
IN UTERO EFFECTS ON FETUS
Miscarriage [aOR=2.11 (48), fetal death, and stillbirth (pooled RR 1.26) (49)]
Restricted fetal growth and low birth weight [pooled RR 1.82 (49)]
Alteration of development of fetal airways (50)
Cleft palate (51)
IN UTERO EFFECTSAFFECTING POSTNATAL LIFE (52)
Reduced respiratory drive and arousal responses in infant (50)
Sudden unexpected death of infancy [pooled aOR=2.25 (53)]
Hospitalization in infancy [aOR=1.52 (54)]
Invasive meningococcal disease [pOR=2.93 (55)]
LRI and bronchitis in young children (50)
Infant wheezing [aOR=4.9 (56), pOR=1.4 (57)]
Asthma [≤2 years pOR=1.85; 5–18 years pOR=1.23 (57)]
Asthma in adolescent girls [aOR ∼2 (58)]
Decreased lung function in adolescent boys (59)
Reduced response to inhaled corticosteroids in children with asthma (60)
Learning difficulties, behavioral problems, and ADHD (61)
Sensorineural hearing loss [aOR=1.83 (62)]
Gestational diabetes in females (63)
Obesity [aOR 1.5–2.65 (64–66)]
Pyloric stenosis [aOR 2.0 (67)]
Smoking initiation [OR 2.1–2.7 (68)]
POSTNATAL EXPOSURE EFFECTS ONYOUNG CHILDREN
Sudden unexpected death of infancy [pooled independent aOR=1.97 (53)]
Respiratory tract infections including pneumonia, bronchiolitis, bronchitis, pharyngotonsillitis, sinusitis, otitis media, and the common cold [1.5- to 4-fold
risks (61, 69)]
Increased severity of influenza (70)
Invasive meningococcal disease [pOR=2.26 (55)]
Wheezing [≤2 years pOR 1.7, 5–18 years pOR=1.2–1.4 (57)] asthma [≤2 years pOR=2.47 (57)); pOR=1.32, pooled aOR 1.27 (71)
High blood pressure (72)
Learning difficulties, behavior problems, and ADHD (61)
Childhood and adult cancers (43, 47)
Increased severity of asthma (73–76)
Decreased pulmonary function (57, 59, 77–79)
Injury from house fires (24)
EXPOSURE IN LATER CHILDHOODANDADOLESCENCE
Respiratory infections, severe asthma, and decreased pulmonary function (as above)
Diastolic blood pressure [aOR=2.25 (80)]
Adverse changes in serum lipids (81, 82)
Developing the metabolic syndrome [aOR=4.7 (83)]
Smoking initiation (11, 12)
OR, odds ratio; aOR, adjusted odds ratio; pOR, pooled odds ratio; RR, relative risk.
people, and perpetuates a transgenerational cycle of smoking initi-
ation. For these reasons elimination of smoking in pregnancy and
in parents is an absolutely key issue for the immediate and future
health of the population, and for reduction of uptake of tobacco
smoking by the young.
A MATTER OF GLOBAL INJUSTICE AND ENVIRONMENTAL
CONCERN
Whereas once cigarette smoking was the luxury of the elite, it is
now heavily overrepresented in lower socioeconomic, and disad-
vantaged minority groups, who have the least resources to be able
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to cope with the health effects, or advocate on their own behalf.
Tobacco marketing has targeted these groups (17–19).
The inequity of exposure and health effects extends to the inter-
national and global scene. Tobacco companies, like many other
industries, have exploited the emerging and developing countries
of the world in China (the world’s largest tobacco-growing nation),
India, Africa, and South America. Tobacco has been offered as
a quick cash crop to peasant farmers who become locked into
dependence on the industry supply of fertilizers, and often enter
a debt trap, because tobacco impoverishes the soil (20). In 1999
it was estimated that over 200,000 hectares of forest or woodland
were cleared every year in developing countries for tobacco plan-
tations and to fuel the curing of tobacco (21, 22). And thousands
of children are employed in unsafe and toxic conditions in tobacco
manufacturing plants and in the extensive home-based manufac-
ture of bidis (cheap cigarettes) in India, China, and other countries
(13, 23, 24).
For these reasons tobacco use is a global cause of injustice
and environmental concern, and is not just an issue of personal
health (25). The WHO Framework Convention on Tobacco Con-
trol (2003) required signatory nations to meet key core principles
and objectives from February 2005 (26). Hard-hitting legislation –
including increased taxation, the banning of sales to minors, the
banning of smoking in workplaces, restaurants, bars, casinos, the
removal of vending machines and tobacco point-of-sale displays,
requiring package health warnings and media campaigns – has
been effective in reducing smoking rates in many countries to
levels below 20%. In 2007, Frieden and Bloomberg estimated that
reduction of smoking prevalence from 25 to 20% worldwide would
prevent 73 million premature deaths in adults, 50 million deaths
in children, and 50 million antenatal deaths by 2030 (27).
Legislation on the table for many countries includes plain-
packaging (following Australia’s lead), banning smoking in cars
carrying children, in parks and beaches, and regulation of tobacco
constituents1. There is evidence that these approaches will further
reduce smoking levels. Aotearoa/New Zealand has committed to
being a smoke-free country (defined as a smoking prevalence of
less than 5%) by 2025.
THE WOMB AND THE HOME – STILL UNPROTECTED
And yet, as Tobacco Endgame conferences presage the demise of
tobacco sales and smoking, the greatest area of harm to children
remains the womb and the home, where legislation’s arm often falls
short. Almost half of the world’s children who never smoked are
exposed to tobacco smoke in the home (13). Many countries have
legislated against physical punishment of children, and against
neglect or leaving children younger than a certain age on their own
at home. Can the home be protected from smoke by legislation,
and how will it be regulated? We know that smoking outside the
house does not protect children (9). We also know that measures
directly addressing education of young people and teenagers are
often not effective on their own in preventing smoking initiation
1Note that harm reduction strategies that involve substituting cigarettes with smoke-
less forms of tobacco (electronic cigarettes etc) rather than cessation are not ideal
because of the toxicity of nicotine itself to the fetus, to the child, and to the germline.
See paragraph 1.
(28). The only effective way to reduce smoking exposure in the
home is for parents to give up smoking. Similarly the best way
to change the image of tobacco from being seen by young peo-
ple as a desirable badge of adult, independent status is for adult
smokers in their childbearing years to give up smoking. We need
continuing research efforts into the best way to counter media
advertising, provide positive media messages, and make smoking
cessation attractive as well as feasible to the majority of smokers.
FROM CORPORATE SOCIAL RESPONSIBILITY TO
CHALLENGING PUBLIC HEALTH LEGISLATION
The other major challenge that is being faced comes from a new
tactic of the tobacco industry. Since the early 90s the industry has
often tried to portray itself as a caring, community-responsible
enterprise that has no wish to advertise to children or young people
and supports educational activities. For example a tobacco com-
pany produced and distributed an education package for schools in
Australia and New Zealand on responsible decision-making (“I’ve
got the Power”),and another is a sponsor for the Keep New Zealand
Beautiful trust. Through such initiatives (part of the public rela-
tions front termed “Corporate Social Responsibility” (29, 30)) the
industry has tried to maintain this image, despite continuing to
market a deadly product, and to use product placement in movies
attractive to young people. Part of this has been an industry tactic
to emphasize that smoking is an adult behavior, with the double
effect of appearing to discourage youth smoking while doing the
opposite, because youth seek to emulate adult behaviors (31).
“Acting in a manner that draws the clearest, sharpest possible line
between who should and who should not have access to cigarettes will
reinforce the right of adults to obtain and enjoy a legal product, and
thus prevent marketing bans down the road that are driven by the
youth access issue.” (Speech Presented at Philip Morris Invitational
in 1995 (32)).
Now, as plain-packaging legislation has been enacted in Aus-
tralia, and is planned in many other countries, including the UK
and New Zealand, the tobacco industry has started to use tac-
tics directly opposed to public health and the public good. Big
Tobacco is pitting its massive financial might against governments
through trade agreements, alleging threats to the industry’s profits
and trading based on their intellectual property – including their
logos and package design (33). This is clearly an area that bites
deeply. Challenges have been brought to Australia based on the
legislation being unconstitutional (this challenge has been over-
turned by the Australian High Court), being a technical barrier to
trade (an action brought by several countries through the World
Trade Organization, with legal support from tobacco companies)
and being in breach of a longstanding trade agreement between
Australia and Hong Kong (an industry shifted their office to Hong
Kong in order to bring this dispute).
Australia has commendably not backed down on the legisla-
tion and has good reasons for defeating the challenges. But this
will not be achieved without considerable legal expense (predicted
to exceed AUD $10 million), and this has already resulted in a
“chilling” effect – a delay in the planned introduction of plain
packaging by the New Zealand government, and other govern-
ments (34). New Zealand and several other Pacific nations are at
the same time negotiating a “new generation” trade agreement
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which is predicted to have a much greater reach into domestic
policy. The Trans Pacific Partnership is backed by the US Foreign
Trade Representative, and several tobacco companies have already
intimated that they are prepared to use such an agreement to lit-
igate to protect their investments (including intellectual property
such as logos and packaging) if necessary (33–35). Tobacco com-
panies and tobacco-growing states have major influence in US
trade, regardless of the denouncement of tobacco by the US Sur-
geon General. It is essential that tobacco control strategies and the
medical and legal professions work together to advocate against
the loss of democratic powers and public health muscle that are
potentially put on sale for the sake of trade.
AN UNETHICAL INDUSTRY CAN BE RUN BY DECENT PEOPLE
WITH A BLIND SPOT
The tobacco industry is unethical and immoral in that it continues
to manufacture and market a lethal, addictive, and child-damaging
product in full knowledge of these effects. The industry thus dis-
plays a disregard for human life, for the rights of children, for the
status of the poor, and for the environment. Tobacco corporations
have made duplicitous statements in public and in their public
relations efforts that have been termed “Corporate Social Respon-
sibility” as noted above. This is not to say that every worker in
the industry is corrupt, but the industry and its corporate entities
exhibit this unethical behavior and ethos. Many tobacco industry
workers may have blind spots in regards to the medical, social, and
environmental damage caused by their company. The controlling
story within tobacco companies is not that of an unethical busi-
ness producing a lethal and child-damaging product, but rather of
a thriving business (despite attacks from fringe medical scientists)
that benefits the community and country, treats its workers well
and offers good job security, much like a food or pharmaceutical
corporation (36). There has been little research into how tobacco
industry employes may be best educated about the damage to the
public. One interfaith group has bought industry shares in order to
challenge and influence company policy, with some success (37).
A multi-pronged tobacco control strategy continues to be
required (Figure 1) because of the many ways in which the indus-
trial and legal might of the tobacco industry can be brought to bear
to circumvent, penetrate, or challenge smoke-free measures and
legislation. As child health professionals, our goal is that every child
experiences their right to grow up in a smoke-free environment.
FIGURE 1 | Multi-pronged approach to reducing tobacco-related mortality, morbidity, and smoking initiation among children, focused on reducing
smoking prevalence in adults.
Frontiers in Pediatrics | Pediatric Pulmonology August 2013 | Volume 1 | Article 20 | 4
Pattemore Tobacco or healthy children
At the same time we must never assume that the tobacco
industry is going to roll over and surrender, or transmute into
a charitable agency.
THE ONGOING FIGHT WITH A FORMIDABLE OPPONENT
The tobacco companies have more economic and legal might than
many countries. In countries like America and China they have
entangled themselves in every stratum of politics and economics,
from farmer benefits, to states, to congress and government trade
agencies (36) (although their proportional contribution to these
countries’economies may be overstated (38)). The WHO estimates
that the number of smokers worldwide will increase from 1.1 to
1.6 billion by 2025 (13). So what hope do we have? Are we con-
demned after each public health gain to expect ever-augmented
strength from the industry?
The outcome cannot be predicted with certainty, but our stance
as child health professionals and respiratory specialists is clear.
We must expose and oppose the injustice to the young and the
marginalized that we see on a massive and largely unappreci-
ated scale. What we do has ramifications beyond just tobacco. The
alcohol industry has been following the tobacco industry’s strate-
gies closely, emphasizing personal responsibility and targeting the
“problem drinker” rather than the industry taking responsibility
for its own product and marketing to youth. Other industries that
are operating at the cost of health interests may follow.
What counts in our favor is that we have a transparent agenda
that is in the child’s and the community’s best interests, that
is devoid of vested interests, that truly captures the moral high
ground, and has the support of the international community,
WHO and most of our governments (albeit that governments are
always having to deal a large hand to trade interests). As with those
who opposed the slave trade, we cannot underestimate the strength
of the financial and corporate interests opposing change, but we
have a responsibility to act and refuse to stand down on behalf of
those who cannot advocate for themselves. This is a war that can
be won, but it requires major commitment on our part, ongoing
research into key aspects of tobacco control, and ongoing dialog
with our health departments and governments.
To conclude, it is naturally of direct relevance to pediatric pul-
monologists that tobacco smoke from conception onward has
major effects on the development, functioning, and wellness of
the entire respiratory system, and through the respiratory system
on sudden infant death syndrome, meningococcal disease, and
many other systemic diseases. It poses a long-term risk for adult
chronic cardiorespiratory disease, and for smoking initiation, with
its own incumbent risks. As well as this, we should be aware that
growth and manufacture of tobacco products pose global risks to
the health and wellbeing of children.
For the practicing pediatrician and pediatric pulmonologist it
is vital that we consistently ask parents and older children about
smoking. For parents and expectant parents who smoke it is help-
ful to ask about their willingness to quit, to advise them strongly
to quit (in a brief sentence), and to provide them with verbal
and/or written information about the risks to their children and
even grandchildren of exposure. Brief motivational interviewing
is an accepted method of doing this (39). Children and adoles-
cents who are smokers are more difficult to advise and counsel
effectively: helpfulness and clear advice to quit are important.
Parents who are smokers and are willing to quit should be
reminded of the positive immediate aspects of quitting (improved
child health, improved breath, taste, fitness etc.), encouraged to
set a quit date, and provided with nicotine replacement. Referral
to a smoking cessation provider should be offered, and follow-up
arranged. For those who relapse they should be congratulated for
trying, encouraged that relapse is part of the process of quitting,
and assisted to learn from their attempt.
As expert leaders in our organizations and communities we
should endeavor to speak up about the impact of tobacco exposure
and marketing on our children, and the impact of the industry on
the environment and children in the developing world. This may
involve discussing the effects of tobacco smoke with colleagues
such as obstetricians, input into smoke-free initiatives, letters to
the media or to MPs, and lobbying of governments for protection
of children through legislation. We should also be asking our gov-
ernments about the effects of their trade relationships with the
tobacco industry or tobacco exporting states on public health and
on global injustice to children and families.
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